| 1 |
31137171 | [Feasibility and toxicity of EC-T dose-dense adjuvant chemotherapy: A real world study in Chinese early-stage breast cancer patients with high recurrence risk]. | 2019 May 23 |
1 |
| 2 |
31502114 | Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study. | 2019 Nov |
1 |
| 3 |
24595405 | Reducing febrile neutropenia rates in early breast cancer. Experience of two UK cancer centres. | 2014 Aug |
2 |
| 4 |
20437856 | Long-term results of a pilot study on an intensive induction regimen for unresectable stage III non-small-cell lung cancer. | 2010 Jan-Feb |
1 |
| 5 |
18806833 | EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells. | 2009 Feb |
1 |
| 6 |
19218307 | Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer. | 2009 Jul |
1 |
| 7 |
17453364 | Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer. | 2007 |
1 |
| 8 |
17716984 | A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes. | 2007 Oct |
1 |
| 9 |
17762397 | Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study. | 2007 Jul |
1 |
| 10 |
16769988 | Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide? | 2006 Jul 1 |
3 |
| 11 |
15865083 | Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer. | 2005 Mar-Apr |
1 |
| 12 |
15685835 | Irinotecan, epirubicin, and capecitabine in metastatic adenocarcinomas: preliminary results of a phase I study. | 2004 Dec |
2 |
| 13 |
12926135 | Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer. | 2003 May-Jun |
1 |
| 14 |
12039931 | First-line treatment with epirubicin and vinorelbine in metastatic breast cancer. | 2002 Jun 1 |
1 |
| 15 |
12419756 | Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics. | 2002 Nov |
1 |
| 16 |
11304774 | Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group. | 2001 Apr 15 |
1 |
| 17 |
11583191 | Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients. | 2001 Aug |
1 |
| 18 |
11720428 | Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy. | 2001 Nov 16 |
3 |
| 19 |
11016746 | Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study. | 2000 Jul |
1 |
| 20 |
10378632 | A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor. | 1999 |
1 |
| 21 |
10516673 | Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease. | 1999 Oct |
1 |
| 22 |
10561191 | Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison. | 1999 Apr |
1 |
| 23 |
9720473 | A dose finding study for the combination of epidoxorubicin and vinorelbine, delivered every two weeks with G-CSF support, in advanced breast cancer. | 1998 Aug |
1 |
| 24 |
9390210 | A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group. | 1997 Oct |
1 |
| 25 |
8645591 | A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer. | 1996 Jun |
1 |
| 26 |
8742097 | Different doses of granulocyte colony stimulating factor to support a weekly chemotherapeutic regimen in advanced gastric cancer: a randomized study. | 1996 Jan |
2 |
| 27 |
7526143 | High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group study. | 1995 Jan |
2 |
| 28 |
7533518 | The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancer. | 1995 Mar |
1 |
| 29 |
7538704 | Intensive weekly chemotherapy for elderly gastric cancer patients, using 5-fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin and glutathione with the support of G-CSF. | 1995 Jan-Feb |
1 |
| 30 |
7577476 | Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM). | 1995 Nov |
2 |
| 31 |
7691117 | Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer. | 1993 |
1 |